Autopsy report · NCT01395485

Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma

“The study had been cancelled and replaced with protocol 20130250.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Amgen

Sponsor type

Industry

Conditions

Asthma

Interventions

AMG 827 or Placebo

Participants

0

Trials that died the same way

• Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
  “Protocol review had expired and the study had previously been Suspended. There was no funding to continue the study.” (72% match in meaning)
• Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
  “Per protocol, the study was terminated based on interim analysis results” (70% match in meaning)
• Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  “The study was terminated due to excessive toxicity and low compliance to the protocol scheme.” (69% match in meaning)
• Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
  “Study was cancelled by Sponsor.” (68% match in meaning)
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
  “Protocol was cancelled by company based on overall efficacy, no safety concern” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.